Cabaletta Begin Period Cash Flow vs Cash Per Share Analysis

CABA Stock

USD 1.77 0.08 4.32%

Cabaletta Bio financial indicator trend analysis is way more than just evaluating Cabaletta Bio prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cabaletta Bio is a good investment. Please check the relationship between Cabaletta Bio Begin Period Cash Flow and its Cash Per Share accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cabaletta Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.

Begin Period Cash Flow vs Cash Per Share

Begin Period Cash Flow vs Cash Per Share Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cabaletta Bio Begin Period Cash Flow account and Cash Per Share. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Cabaletta Bio's Begin Period Cash Flow and Cash Per Share is 0.81. Overlapping area represents the amount of variation of Begin Period Cash Flow that can explain the historical movement of Cash Per Share in the same time period over historical financial statements of Cabaletta Bio, assuming nothing else is changed. The correlation between historical values of Cabaletta Bio's Begin Period Cash Flow and Cash Per Share is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Begin Period Cash Flow of Cabaletta Bio are associated (or correlated) with its Cash Per Share. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash Per Share has no effect on the direction of Begin Period Cash Flow i.e., Cabaletta Bio's Begin Period Cash Flow and Cash Per Share go up and down completely randomly.

Correlation Coefficient

0.81

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Cash Per Share

Most indicators from Cabaletta Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cabaletta Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cabaletta Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.At present, Cabaletta Bio's Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Issuance Of Capital Stock is expected to grow to about 223.6 M, whereas Enterprise Value Over EBITDA is projected to grow to (11.06).

	2022	2023	2024	2025 (projected)
Total Operating Expenses	54.1M	74.7M	85.9M	90.2M
Research Development	39.3M	55.4M	63.7M	66.9M

Total Operating Expenses Research Development

Cabaletta Bio fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Surpluse	Other Stockholder Equity	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Other Assets	Other Current Assets	Deferred Long Term Liab	Property Plant And Equipment Net	Property Plant And Equipment Gross	Property Plant Equipment	Retained Earnings Total Equity	Short Term Investments
Total Assets		0.97	0.97	0.99	0.81	-0.96	-0.93	0.97	0.99	1.0	0.78	-0.08	0.93	0.96	0.36	0.99	1.0	1.0	-0.4	0.85	-0.71	0.86	0.89	0.77	-0.8	0.87
Other Current Liab	0.97		0.97	0.97	0.78	-0.93	-0.93	0.97	0.97	0.97	0.78	-0.12	0.93	0.97	0.31	0.97	0.97	0.97	-0.38	0.76	-0.7	0.82	0.86	0.76	-0.84	0.83
Total Current Liabilities	0.97	0.97		0.97	0.73	-0.89	-0.98	1.0	0.94	0.97	0.82	-0.11	0.93	1.0	0.34	0.97	0.97	0.96	-0.3	0.74	-0.73	0.93	0.95	0.85	-0.88	0.92
Total Stockholder Equity	0.99	0.97	0.97		0.83	-0.96	-0.93	0.96	0.99	0.99	0.8	-0.18	0.94	0.95	0.26	1.0	0.99	0.99	-0.41	0.86	-0.7	0.85	0.88	0.77	-0.79	0.87
Net Tangible Assets	0.81	0.78	0.73	0.83		-0.91	-0.76	0.7	0.85	0.81	0.62	-0.2	0.91	0.71	0.16	0.83	0.82	0.82	-0.11	0.91	-0.3	0.58	0.59	0.65	-0.69	0.48
Net Debt	-0.96	-0.93	-0.89	-0.96	-0.91		0.89	-0.89	-0.98	-0.96	-0.72	0.05	-0.94	-0.87	-0.36	-0.96	-0.96	-0.97	0.36	-0.91	0.51	-0.73	-0.76	-0.72	0.77	-0.72
Retained Earnings	-0.93	-0.93	-0.98	-0.93	-0.76	0.89		-0.97	-0.91	-0.93	-0.83	0.1	-0.94	-0.97	-0.37	-0.93	-0.93	-0.92	0.16	-0.73	0.58	-0.94	-0.95	-0.91	0.93	-0.87
Accounts Payable	0.97	0.97	1.0	0.96	0.7	-0.89	-0.97		0.94	0.97	0.82	-0.08	0.91	0.99	0.37	0.96	0.97	0.96	-0.32	0.73	-0.74	0.93	0.95	0.84	-0.87	0.93
Cash	0.99	0.97	0.94	0.99	0.85	-0.98	-0.91	0.94		0.99	0.74	-0.06	0.94	0.93	0.35	0.99	1.0	1.0	-0.4	0.88	-0.67	0.8	0.83	0.73	-0.77	0.82
Cash And Short Term Investments	1.0	0.97	0.97	0.99	0.81	-0.96	-0.93	0.97	0.99		0.78	-0.08	0.93	0.95	0.35	0.99	1.0	1.0	-0.41	0.85	-0.71	0.86	0.88	0.77	-0.79	0.87
Common Stock Shares Outstanding	0.78	0.78	0.82	0.8	0.62	-0.72	-0.83	0.82	0.74	0.78		-0.35	0.72	0.82	0.1	0.8	0.77	0.77	-0.3	0.69	-0.41	0.8	0.82	0.9	-0.72	0.81
Non Current Liabilities Total	-0.08	-0.12	-0.11	-0.18	-0.2	0.05	0.1	-0.08	-0.06	-0.08	-0.35		-0.15	-0.13	0.88	-0.18	-0.07	-0.07	0.06	-0.15	0.08	-0.1	-0.11	-0.1	0.11	-0.1
Capital Surpluse	0.93	0.93	0.93	0.94	0.91	-0.94	-0.94	0.91	0.94	0.93	0.72	-0.15		0.91	0.28	0.94	0.93	0.93	-0.1	0.83	-0.56	0.82	0.83	0.8	-0.89	0.72
Other Stockholder Equity	0.96	0.97	1.0	0.95	0.71	-0.87	-0.97	0.99	0.93	0.95	0.82	-0.13	0.91		0.32	0.95	0.95	0.95	-0.31	0.69	-0.72	0.93	0.95	0.85	-0.87	0.92
Total Liab	0.36	0.31	0.34	0.26	0.16	-0.36	-0.37	0.37	0.35	0.35	0.1	0.88	0.28	0.32		0.26	0.35	0.35	-0.04	0.21	-0.15	0.33	0.33	0.35	-0.32	0.31
Net Invested Capital	0.99	0.97	0.97	1.0	0.83	-0.96	-0.93	0.96	0.99	0.99	0.8	-0.18	0.94	0.95	0.26		0.99	0.99	-0.41	0.86	-0.7	0.85	0.88	0.77	-0.79	0.87
Total Current Assets	1.0	0.97	0.97	0.99	0.82	-0.96	-0.93	0.97	1.0	1.0	0.77	-0.07	0.93	0.95	0.35	0.99		1.0	-0.41	0.85	-0.7	0.85	0.88	0.77	-0.79	0.87
Net Working Capital	1.0	0.97	0.96	0.99	0.82	-0.97	-0.92	0.96	1.0	1.0	0.77	-0.07	0.93	0.95	0.35	0.99	1.0		-0.42	0.86	-0.7	0.85	0.87	0.76	-0.78	0.86
Other Assets	-0.4	-0.38	-0.3	-0.41	-0.11	0.36	0.16	-0.32	-0.4	-0.41	-0.3	0.06	-0.1	-0.31	-0.04	-0.41	-0.41	-0.42		-0.28	0.42	-0.13	-0.17	0.02	-0.14	-0.42
Other Current Assets	0.85	0.76	0.74	0.86	0.91	-0.91	-0.73	0.73	0.88	0.85	0.69	-0.15	0.83	0.69	0.21	0.86	0.85	0.86	-0.28		-0.4	0.62	0.64	0.64	-0.61	0.61
Deferred Long Term Liab	-0.71	-0.7	-0.73	-0.7	-0.3	0.51	0.58	-0.74	-0.67	-0.71	-0.41	0.08	-0.56	-0.72	-0.15	-0.7	-0.7	-0.7	0.42	-0.4		-0.69	-0.71	-0.38	0.47	-0.78
Property Plant And Equipment Net	0.86	0.82	0.93	0.85	0.58	-0.73	-0.94	0.93	0.8	0.86	0.8	-0.1	0.82	0.93	0.33	0.85	0.85	0.85	-0.13	0.62	-0.69		1.0	0.9	-0.85	0.95
Property Plant And Equipment Gross	0.89	0.86	0.95	0.88	0.59	-0.76	-0.95	0.95	0.83	0.88	0.82	-0.11	0.83	0.95	0.33	0.88	0.88	0.87	-0.17	0.64	-0.71	1.0		0.9	-0.86	0.96
Property Plant Equipment	0.77	0.76	0.85	0.77	0.65	-0.72	-0.91	0.84	0.73	0.77	0.9	-0.1	0.8	0.85	0.35	0.77	0.77	0.76	0.02	0.64	-0.38	0.9	0.9		-0.87	0.8
Retained Earnings Total Equity	-0.8	-0.84	-0.88	-0.79	-0.69	0.77	0.93	-0.87	-0.77	-0.79	-0.72	0.11	-0.89	-0.87	-0.32	-0.79	-0.79	-0.78	-0.14	-0.61	0.47	-0.85	-0.86	-0.87		-0.71
Short Term Investments	0.87	0.83	0.92	0.87	0.48	-0.72	-0.87	0.93	0.82	0.87	0.81	-0.1	0.72	0.92	0.31	0.87	0.87	0.86	-0.42	0.61	-0.78	0.95	0.96	0.8	-0.71

Click cells to compare fundamentals

Cabaletta Bio Account Relationship Matchups

Cabaletta Bio fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	114.7M	126.3M	117.0M	253.7M	291.7M	306.3M
Other Current Liab	3.9M	6.0M	2.7M	7.9M	9.1M	9.5M
Total Current Liabilities	5.2M	8.4M	9.5M	16.0M	18.4M	19.3M
Total Stockholder Equity	109.5M	118.0M	104.5M	236.2M	271.6M	285.2M
Net Tangible Assets	138.3M	109.5M	116.6M	104.5M	120.2M	84.0M
Net Debt	(101.4M)	(122.2M)	(76.5M)	(188.2M)	(169.4M)	(160.9M)
Retained Earnings	(66.3M)	(112.6M)	(165.6M)	(233.2M)	(209.9M)	(199.4M)
Accounts Payable	1.2M	2.3M	2.5M	4.5M	5.2M	5.5M
Cash	101.4M	122.2M	81.6M	193.2M	222.2M	233.3M
Non Current Assets Total	1.2M	1.8M	8.1M	9.2M	10.5M	11.1M
Non Currrent Assets Other	299K	357K	565K	1.7M	2.0M	2.1M
Cash And Short Term Investments	108.7M	122.2M	106.5M	241.2M	277.4M	291.3M
Common Stock Shares Outstanding	23.1M	25.7M	29.3M	40.9M	47.1M	28.3M
Liabilities And Stockholders Equity	114.7M	126.3M	117.0M	253.7M	291.7M	306.3M
Non Current Liabilities Total	1.2M	2.3M	3.0M	1.5M	1.3M	1.2M
Capital Surpluse	1.8M	171.3M	175.8M	270.1M	310.6M	326.2M
Other Stockholder Equity	175.8M	230.5M	270.1M	469.4M	539.8M	566.8M
Total Liab	5.2M	8.4M	12.4M	17.5M	15.7M	10.5M
Net Invested Capital	109.5M	118.0M	104.5M	236.2M	271.6M	285.2M
Total Current Assets	113.5M	124.5M	108.8M	244.5M	281.2M	295.2M
Net Working Capital	108.4M	116.2M	99.3M	228.5M	262.8M	275.9M
Other Assets	299.0	357K	565K	1.0	1.15	1.09
Other Current Assets	1.9M	2.3M	2.3M	3.2M	3.7M	2.8M
Property Plant And Equipment Net	890K	1.4M	7.6M	7.5M	8.6M	9.0M
Property Plant And Equipment Gross	890K	2.6M	9.9M	11.2M	12.9M	13.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
CRM	Salesforce
CRM	Salesforce

When determining whether Cabaletta Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cabaletta Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cabaletta Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cabaletta Bio Stock:

How To Invest In Cabaletta

Details

Is Cabaletta Stock a good investment?

Details

What is Cabaletta Bio's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cabaletta Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.

You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cabaletta Bio. If investors know Cabaletta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cabaletta Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.16)

Return On Assets

(0.38)

Return On Equity

(0.62)

The market value of Cabaletta Bio is measured differently than its book value, which is the value of Cabaletta that is recorded on the company's balance sheet. Investors also form their own opinion of Cabaletta Bio's value that differs from its market value or its book value, called intrinsic value, which is Cabaletta Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cabaletta Bio's market value can be influenced by many factors that don't directly affect Cabaletta Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Cabaletta Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cabaletta Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cabaletta Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cabaletta Begin Period Cash Flow vs Cash Per Share Analysis

Begin Period Cash Flow vs Cash Per Share

Begin Period Cash Flow vs Cash Per Share Correlation Analysis

Correlation Coefficient

Begin Period Cash Flow

Cash Per Share

Cabaletta Bio fundamental ratios Correlations

Cabaletta Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cabaletta Bio fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Working Capital	+ 1.0	Total Assets
Accounts Payable	+ 1.0	Total Current Liabilities
Other Stockholder Equity	+ 1.0	Total Current Liabilities
Net Invested Capital	+ 1.0	Total Stockholder Equity

Cash	- 0.98	Net Debt
Retained Earnings	- 0.98	Total Current Liabilities
Other Stockholder Equity	- 0.97	Retained Earnings
Accounts Payable	- 0.97	Retained Earnings
Net Working Capital	- 0.97	Net Debt
Total Current Assets	- 0.96	Net Debt